SNAKEBITES: ​ Little hope of cure for the most vulnerable

17 days to go before last batch for only proven safe and effective antivenom to treat snakebites from different types of snakes across Sub-Saharan Africa expires at the end of June

Dear media colleagues,

You will recall Doctors Without Borders (MSF) raising alarm in September 2015 about snakebites as being a major killer and while the world’s health community remains trapped in in-action, thousands of people continue to die or risk permanent disability.

Every year 5 million people are bitten by snakes worldwide with 1 in 10 risking death or permanent disability. Of these, about 30 000 people in Sub-Saharan Africa die from snakebite – roughly the equivalent of the number of deaths from meningitis annually.

We also warned that the only proven safe and effective antivenom to treat snakebites from different types of snakes across Sub-Saharan Africa, Fav-Afrique, will soon be unavailable as the last batch expires at the end of this month. Fav Afrique is produced by a French pharmaceutical company Sanofi.

Now, just 17 days from expiry, MSF once again calls for action to tackle snakebite as a global health emergency instead of a lingering neglected public health issue it remains today.

At MSF, we will have to adapt the way we treat our patients once the FAV-Afrique expires, but we are uncertain what impact the treatment will have.  

We are calling on governments and health bodies to provide safe, effective and affordable treatments urgently since treatment is very costly and not available to those who need it most.

For snakebite victims in South Sudan like Nyekuony (35) and Nyajinma  (6), getting treatment remains a struggle and this is just symptomatic of a wide crisis. It can cost up to US$250 (R3,796) to treat one patient from a snakebite - an equivalent of two years’ salary for some people.

Today we share with you Nyekuony and Nyajinma’s stories to highlight the urgency of the situation and show what many people grapple with in order to access treatment for this neglected health condition.    

Regards

Angela 

Angela Makamure

Press Officer, Doctors Without Borders (MSF) Southern Africa

Share

Latest stories

Website preview
A shot of urgency: Five key pathways to reach more people with lifesaving vaccines
Vaccines save millions of lives every year. They reduce the risks of getting a disease by working with the body’s natural defences to build protection against vaccine-preventable diseases. Immunisation – the process of protecting the human body against infectious disease, typically through vaccination administration – currently prevents 3.5 million to 5 million deaths every year from vaccine-preventable diseases like diphtheria, tetanus, pertussis (whooping cough), influenza, and measles. Vaccines are also very important in preventing and controlling infectious disease outbreaks.
msf-sa-press.prezly.com
Website preview
SA: MSF Calls on Business Leaders to Drive Impact at Inaugural Golf Day in Johannesburg
Doctors Without Borders (MSF) Southern Africa is calling on golf enthusiasts, business leaders, healthcare advocates, and humanitarians to take action at its inaugural Golf Day, an initiative aimed at raising critical funds to support its global medical humanitarian work amid mounting needs.
msf-sa-press.prezly.com
Website preview
Nigeria: 350,000 children vaccinated against crippling diphtheria epidemic
The humanitarian medical organisation Doctors Without Borders (MSF) and the Borno State Ministry of Health have successfully completed a vaccination campaign against diphtheria targeting children until 14 years old in Maiduguri Metropolitan Council (MMC) Local Government Area (LGA) in Nigeria’s Borno state.
msf-sa-press.prezly.com

About Doctors Without Borders (MSF) Southern Africa

Contact

70 Fox Street, 7th Floor Marshalltown, Johannesburg South Africa

011 403 4440

DL-JNB-Joburg-Press@joburg.msf.org

www.msf.org.za